Avoro Capital Advisors’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,590,000	Closed	-$294M	–	46
2024 Q1	$294M	Buy	+3,590,000	New	+$294M	3.43%	12
2018 Q3	–	Sell	-4,471,300	Closed	-$42.4M	–	46
2018 Q2	$42.4M	Buy	+4,471,300	New	+$42.4M	1.63%	21